These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 454528)

  • 41. Assay of liver membrane insulin receptors in obese, hyperglycaemic (ob/ob) mice: stimulant effect of an oral antidiabetic sulphonylurea drug [proceedings].
    Greenstein BD
    Br J Pharmacol; 1979 May; 66(1):86P. PubMed ID: 454969
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical use of oral hypoglycemic agents.
    Hagg SA
    Am J Hosp Pharm; 1976 Sep; 33(9):943-7. PubMed ID: 790951
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients.
    Tseng CH; Huang TS
    Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of glimepiride on the electrical activity of isolated rabbit heart muscle.
    Ballagi-Pordány G; Németh M; Aranyi Z; Kékesi E; Koltai MZ; Papp G; Pogátsa G
    Arzneimittelforschung; 1992 Feb; 42(2):111-3. PubMed ID: 1610416
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synergistic effect of hypoglycemic sulfonylureas and negative phospholipids on calcium transport: ionic and conformational aspects.
    Deleers M; Grognet P; Mahy M; Brasseur R; Malaisse WJ
    Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):407-24. PubMed ID: 6635329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anti-diabetic agents.
    Biron CR
    RDH; 1995 May; 15(5):32-4. PubMed ID: 10332415
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pharmacodynamics of second generation sulfonylureas: dose-effect curve of gliclazide in type 2 diabetes mellitus].
    Procacci V; Giovine A; Roberto MG; Di Reda N; Lasorsa G; Vendemiale G; Stufano N; Altomare E
    Boll Soc Ital Biol Sper; 1988 Sep; 64(9):817-24. PubMed ID: 3072977
    [No Abstract]   [Full Text] [Related]  

  • 48. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

  • 49. Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes.
    Koyuturk M; Ozsoy-Sacan O; Bolkent S; Yanardag R
    Indian J Exp Biol; 2005 Mar; 43(3):268-71. PubMed ID: 15816415
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thyroid gland function of patients with diabetes in long-term use of glibornuride].
    Reinwein D
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2221. PubMed ID: 4125093
    [No Abstract]   [Full Text] [Related]  

  • 51. When--and how--to use an oral agent.
    Shuman CR
    Med Times; 1980 May; 108(5):77-81, 85-6. PubMed ID: 7374409
    [No Abstract]   [Full Text] [Related]  

  • 52. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
    Haupt E; Beyer J; Schöffling K
    Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effect of 1-butyl-biguanidine on blood clotting in patients with adult-type diabetes].
    Kaniak J; Knapik Z; Kotschy M; Kowal-Gierczak B; Paczyńska D
    Pol Tyg Lek; 1974 Jan; 29(4):137-9. PubMed ID: 4820794
    [No Abstract]   [Full Text] [Related]  

  • 54. [The pharmacological blockade of protein glycosylation in diabetes mellitus using sulfonylurea derivatives and biguanides].
    Lebedeva EA
    Eksp Klin Farmakol; 1996; 59(5):40-2. PubMed ID: 9026209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The "in vitro" effect of gliclazide, a new hypoglycemic agent, on normal human blood platelets].
    Vainer H; Verry M
    Thromb Res; 1974 Apr; 4(4):523-38. PubMed ID: 4215174
    [No Abstract]   [Full Text] [Related]  

  • 56. Ionophoretic property of hypoglycemic sulfonylureas: competition between H+ and Ca2+.
    Deleers M; Couturier E; Mahy M; Gelbcke M; Malaisse WJ
    Ann Endocrinol (Paris); 1981; 42(3):297-9. PubMed ID: 7316466
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacokinetics in man of glysolamide, a low-dose oral antidiabetic drug.
    Runci FM; Cerretani D; Cerri D; Segre G
    Farmaco Prat; 1984 Dec; 39(12):424-30. PubMed ID: 6529984
    [No Abstract]   [Full Text] [Related]  

  • 58. Hypoglycaemic drugs.
    Sarges R
    Prog Med Chem; 1981; 18():191-223. PubMed ID: 7045983
    [No Abstract]   [Full Text] [Related]  

  • 59. [In vitro effect of glysolamide on blood coagulation].
    Dalla Vedova R; Cadel S; Wassermann A
    Boll Chim Farm; 1979 Jan; 118(1):28-30. PubMed ID: 454528
    [No Abstract]   [Full Text] [Related]  

  • 60. [Effect of the oral antidiabetic agent glibornuride on blood coagulation, blood platelets, and fibrinolysis].
    Voss D; Fuchs G; Schneider D; Schneider J
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2219. PubMed ID: 4679252
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.